1. Aghajanian, G. K., Sprouse, J. S., and Rasmussen, K. (1987). Physiology of the midbrain serotonin system. InPsychopharmacology: The Third Generation of Progress (H. Y. Meltzer, Ed.). Raven Press, New York, pp. 141–149.
2. Angermeyer, M. C., Kühn, L., and Goldstein, J. M. (1990). Gender and the course of schizophrenia: Differences in treated outcomes.Schizophr. Bull. 16293–307.
3. Appel, N. M., Mitchell, W. M., Garlick, R. K., Glennon, R. A., Teitler, M., and De Souza, E. B. (1990). Autoradiographic characterization of (±)-1-(2.5-dimethoxy-4-[125l]iodophenyl)-2-aminopropane ([125l]DOI) binding to 5-HT2 and 5-HT1C receptors in rat brain.J. Pharmacol. Exp. Ther. 255843–857.
4. Ashcroft, G. W., Eccleston, D., Murray, L. G., Glen, A. I. M., Crawford, T. B. B., Pullar, I. A., Shields, P. J., Walter, D. S., Blackburn, I. M., Connechan, J., and Lonergan, M. (1972). Modified amine hypothesis for the aetiology of affective illness.Lancet 3573–577.
5. Bleuler, E. (1950).Dementia Praecox or the Group of Schizophrenias International Universities Press, New York.